Beximco Pharmaceuticals (LON:BXP) Trading Up 1.4% - Still a Buy?

Shares of Beximco Pharmaceuticals Limited (LON:BXP - Get Free Report) shot up 1.4% on Thursday . The company traded as high as GBX 36.70 ($0.47) and last traded at GBX 36 ($0.46). 37,663 shares traded hands during trading, a decline of 76% from the average session volume of 157,696 shares. The stock had previously closed at GBX 35.50 ($0.45).

Beximco Pharmaceuticals Stock Performance

The stock has a market cap of £160.60 million, a price-to-earnings ratio of 450.00 and a beta of 0.61. The company has a debt-to-equity ratio of 14.73, a current ratio of 1.80 and a quick ratio of 0.37. The company's fifty day moving average price is GBX 30.53 and its 200-day moving average price is GBX 33.20.

Beximco Pharmaceuticals Company Profile

Beximco Pharmaceuticals Limited manufactures and markets generic pharmaceutical formulations and active pharmaceutical ingredients in Bangladesh. The company provides allergic disorder, analgesics and antipyretic, anti-infective, antiviral, cardiovascular, central nervous system, cough and cold, endocrine and diabetes, eye care, gastrointestinal, hormone and steroid, intravenous fluid, musculoskeletal, oncology, respiratory, urogenital, skin care, vitamin and mineral supplement, and other products, as well as contract manufacturing services to other companies.